Taysha Gene Therapies, Inc. Common Stock
NASDAQ · TSHA
Fundamentals
Market cap
$1.68B
Price / Earnings ratio
-13.0x
Price / Sales ratio
226.0x
Price / Book ratio
8.0x
Return on assets
-0.4%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A


